{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:07:31Z","timestamp":1788822451186,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014114","name":"GW Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014114","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.neuroscience.2020.09.041","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T12:32:16Z","timestamp":1601469136000},"page":"113-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Chronic Treatment with Cannabidiolic Acid (CBDA) Reduces Thermal Pain Sensitivity in Male Mice and Rescues the Hyperalgesia in a Mouse Model of Rett Syndrome"],"prefix":"10.1016","volume":"453","author":[{"given":"Daniele","family":"Vigli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Pellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2020.09.041_b0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1074\/jbc.M111.296020","article-title":"Modulation of L-alpha-lysophosphatidylinositol\/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids","volume":"287","author":"Anavi-Goffer","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0010","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1021\/acs.jnatprod.9b00600","article-title":"Pharmacokinetics of phytocannabinoid acids and anticonvulsant effect of cannabidiolic acid in a mouse model of Dravet syndrome","volume":"82","author":"Anderson","year":"2019","journal-title":"J Nat Prod"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fpls.2016.00019","article-title":"Cannabis sativa: the plant of the thousand and one molecules","volume":"7","author":"Andre","year":"2016","journal-title":"Front Plant Sci"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0020","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2174\/092986711794940888","article-title":"Cannabinoids: occurrence and medicinal chemistry","volume":"18","author":"Appendino","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10882-015-9427-3","article-title":"Pain experience and expression in Rett syndrome: Subjective and objective measurement approaches","volume":"27","author":"Barney","year":"2015","journal-title":"J Develop Phys Disabilities"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","article-title":"Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol","volume":"163","author":"Berrendero","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0035","doi-asserted-by":"crossref","unstructured":"Bhattacherjee A, Winter MK, Eggimann LS, Mu Y, Gunewardena S, Liao Z, Christianson JA, Smith PG (2017) Motor, somatosensory, viscerosensory and metabolic impairments in a heterozygous female rat model of Rett syndrome. Int J Mol Sci 19.","DOI":"10.3390\/ijms19010097"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167965","article-title":"Deletion of Gpr55 results in subtle effects on energy metabolism, motor activity and thermal pain sensation","volume":"11","author":"Bjursell","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0045","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/bph.12043","article-title":"Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation","volume":"168","author":"Bolognini","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0050","doi-asserted-by":"crossref","first-page":"9941","DOI":"10.1073\/pnas.1311685111","article-title":"Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome","volume":"111","author":"Castro","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2006.12.018","article-title":"Early behavioural enrichment in the form of handling renders mouse pups unresponsive to anxiolytic drugs and increases NGF levels in the hippocampus","volume":"178","author":"Cirulli","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0065","doi-asserted-by":"crossref","first-page":"9467819","DOI":"10.1155\/2017\/9467819","article-title":"Persistent unresolved inflammation in the Mecp2-308 female mutated mouse model of Rett syndrome","volume":"2017","author":"Cortelazzo","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0070","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/npp.2011.301","article-title":"Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome","volume":"37","author":"De Filippis","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuropharm.2014.08.010","article-title":"The role of group II metabotropic glutamate receptors in cognition and anxiety: comparative studies in GRM2(-\/-), GRM3(-\/-) and GRM2\/3(-\/-) knockout mice","volume":"89","author":"De Filippis","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0080","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/326184","article-title":"Deficient purposeful use of forepaws in female mice modelling Rett syndrome","volume":"2015","author":"De Filippis","year":"2015","journal-title":"Neural Plasticity"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0085","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/npp.2014.105","article-title":"Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome","volume":"39","author":"De Filippis","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0090","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuropharm.2012.05.048","article-title":"Neonatal exposure to low dose corticosterone persistently modulates hippocampal mineralocorticoid receptor expression and improves locomotor\/exploratory behaviour in a mouse model of Rett syndrome","volume":"68","author":"De Filippis","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1601-183X.2009.00551.x","article-title":"Early postnatal behavioral changes in the Mecp2-308 truncation mouse model of Rett syndrome","volume":"9","author":"De Filippis","year":"2010","journal-title":"Genes Brain Behavior"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11481-009-9177-z","article-title":"Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels","volume":"5","author":"De Petrocellis","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0105","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0110","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1124\/jpet.107.134809","article-title":"Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8","volume":"325","author":"De Petrocellis","year":"2008","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0115","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nprot.2006.170","article-title":"Assessing nest building in mice","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0125","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.neuropharm.2005.11.008","article-title":"Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells","volume":"50","author":"Drysdale","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuropharm.2013.07.024","article-title":"Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors","volume":"75","author":"Espejo-Porras","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-5793(87)81420-5","article-title":"Activation of phospholipase A2 by cannabinoids. Lack of correlation with CNS effects","volume":"211","author":"Evans","year":"1987","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0140","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00401706.1969.10490657","article-title":"Procedures for detecting outlying observations in samples","volume":"11","author":"Grubbs","year":"1969","journal-title":"Technometrics"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0150","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev-cellbio-092910-154121","article-title":"The role of MeCP2 in the brain","volume":"27","author":"Guy","year":"2011","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of Rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/ejpn.2002.0612","article-title":"An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001","volume":"6","author":"Hagberg","year":"2002","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/mrdd.10026","article-title":"Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype","volume":"8","author":"Hoffbuhr","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0170","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0175","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1073\/pnas.1711351114","article-title":"Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome","volume":"114","author":"Kaplan","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0180","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/978-3-642-45106-5_18","article-title":"Brain-derived neurotrophic factor and Rett syndrome","volume":"220","author":"Katz","year":"2014","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0185","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1111\/j.1460-9568.2008.06305.x","article-title":"Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome\u2013Mecp2 gene dosage effects and BDNF expression","volume":"27","author":"Kondo","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/can.2016.0030","article-title":"Palmitoylethanolamide modulates GPR55 receptor signaling in the ventral hippocampus to regulate mesolimbic dopamine activity, social interaction, and memory processing","volume":"2","author":"Kramar","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0195","series-title":"Introducing multivlevel modeling","author":"Kreft","year":"1998"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0200","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.105.093286","volume":"316","author":"Maione","year":"2006","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0205","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1476-5381.2010.01063.x","article-title":"Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action","volume":"162","author":"Maione","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0210","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/FBP.0000000000000185","article-title":"Blockade of GPR55 in the dorsolateral striatum impairs performance of rats in a T-maze paradigm","volume":"27","author":"Marichal-Cancino","year":"2016","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/can.2018.0039","article-title":"Cannabis systematics at the levels of family, genus, and species","volume":"3","author":"McPartland","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0220","unstructured":"Morel A, Demily C (2017) [Social cognition in children with neurogenetic syndromes: A literature review]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie."},{"key":"10.1016\/j.neuroscience.2020.09.041_b0225","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bph.14073","article-title":"Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT1A receptor-mediated suppression of nausea and anxiety in rats","volume":"175","author":"Pertwee","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0230","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/679801","article-title":"IGF1 as a potential treatment for rett syndrome: safety assessment in six Rett patients","volume":"2012","author":"Pini","year":"2012","journal-title":"Autism Res Treatment"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0235","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbr.2011.03.051","article-title":"Cholinergic hypofunction in MeCP2-308 mice: beneficial neurobehavioural effects of neonatal choline supplementation","volume":"221","author":"Ricceri","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0240","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/FBP.0b013e32830c3645","article-title":"Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches","volume":"19","author":"Ricceri","year":"2008","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0245","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuropharm.2012.08.010","article-title":"Rett syndrome treatment in mouse models: searching for effective targets and strategies","volume":"68","author":"Ricceri","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0250","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/hmg\/ddq563","article-title":"Reduced AKT\/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model","volume":"20","author":"Ricciardi","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0255","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s00213-018-5034-1","article-title":"Effect of cannabidiolic acid and (9)-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain","volume":"235","author":"Rock","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0260","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1248\/bpb.34.774","article-title":"Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from Cannabis sativa","volume":"34","author":"Ruhaak","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0265","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1523\/JNEUROSCI.4212-08.2009","article-title":"Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels","volume":"29","author":"Ryan","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0270","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0275","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","article-title":"Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3","volume":"35","author":"Shahbazian","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0280","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1080\/09638288.2016.1212280","article-title":"Building the repertoire of measures of walking in Rett syndrome","volume":"39","author":"Stahlhut","year":"2017","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0285","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/19336950.2019.1619436","article-title":"Diverse TRPV1 responses to cannabinoids","volume":"13","author":"Starkus","year":"2019","journal-title":"Channels"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0290","first-page":"21","article-title":"Investigation of outliers of evaluation scores among school of health instructors using outlier - determination indices","volume":"4","author":"Tabatabaee","year":"2016","journal-title":"J Adv Med Educ Professionalism"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0295","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1124\/dmd.108.020909","article-title":"Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis","volume":"36","author":"Takeda","year":"2008","journal-title":"Drug Metabol Dispos"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0300","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2131\/jts.39.711","article-title":"Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells","volume":"39","author":"Takeda","year":"2014","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0305","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0310","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bjp.0706414","article-title":"Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist","volume":"146","author":"Thomas","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0315","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1021\/np50008a001","article-title":"Constituents of Cannabis sativa L. XVII. A review of the natural constituents","volume":"43","author":"Turner","year":"1980","journal-title":"J Nat Prod"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0320","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/abbs\/gmx073","article-title":"Effects of cannabidiol interactions with Wnt\/beta-catenin pathway and PPARgamma on oxidative stress and neuroinflammation in Alzheimer's disease","volume":"49","author":"Vallee","year":"2017","journal-title":"Acta Biochim Biophy Sin"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0325","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2018.07.029","article-title":"Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome","volume":"140","author":"Vigli","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0330","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1177\/0269881119844184","article-title":"Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice","volume":"33","author":"Zamberletti","year":"2019","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2020.09.041_b0335","doi-asserted-by":"crossref","first-page":"ra94","DOI":"10.1126\/scisignal.2005283","article-title":"Peripheral pain is enhanced by insulin-like growth factor 1 through a G protein-mediated stimulation of T-type calcium channels","volume":"7","author":"Zhang","year":"2014","journal-title":"Sci Signal"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452220306254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452220306254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:01:22Z","timestamp":1759680082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452220306254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":67,"alternative-id":["S0306452220306254"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2020.09.041","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Treatment with Cannabidiolic Acid (CBDA) Reduces Thermal Pain Sensitivity in Male Mice and Rescues the Hyperalgesia in a Mouse Model of Rett Syndrome","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2020.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}